Discordant Quantitative and Visual CT Assessments in the Diagnosis of Emphysema

Iliya P Amaza, Amy M J O'Shea, Spyridon Fortis, Alejandro P Comellas, Iliya P Amaza, Amy M J O'Shea, Spyridon Fortis, Alejandro P Comellas

Abstract

Purpose: Visual assessment of computed tomography (CT) of the lung is routinely employed in the diagnosis of emphysema. Quantitative CT (QCT) can complement visual CT but must be well validated. QCT emphysema is defined as ≥5% of lung volume occupied by low attenuation areas ≤-950 Hounsfield units (LAA-950). Discordant visual and QCT assessments are not uncommon. We examined the association between visual and quantitative chest CT evaluation within a large cohort of subjects to identify variables that may explain discordant visual and QCT findings.

Materials and methods: Volumetric inspiratory CT scans of 1221 subjects enrolled in phase 1 of the COPDGene study conducted at the University of Iowa were reviewed. Participants included never smokers, smokers with normal spirometry, preserved ratio impaired spirometry, and Global Initiative for Obstructive Lung Disease (GOLD) stages I-IV. CT scans were quantitatively scored and visually interpreted by both the COPDGene Imaging Center and the University of Iowa radiologists. Individual-level visual assessments were compared with QCT measurements. Agreement between the two sets of radiologists was calculated using kappa statistic. We assessed variables associated with discordant results using regression methods.

Results: There was a fair agreement for the presence or absence of emphysema between our center's radiologists and QCT (61% concordance, kappa 0.22 [0.17-0.28]). Similar comparisons showed a slight agreement between the COPDGene Imaging Center and QCT (56% concordance, kappa 0.16 [0.11-0.21]), and a moderate agreement between both sets of visual assessments (80% concordance, kappa 0.60 [0.54-0.65]). Current smoking and female gender were significantly associated with QCT-negative but visually detectable emphysema.

Conclusion: The slight-to-fair agreement between visual and quantitative CT assessment of emphysema highlights the need to utilize both modalities for a comprehensive radiologic evaluation. Discordant results may be attributable to one or more factors that warrant further exploration in larger studies.

Clinical trial registration: ClinicalTrials.gov Identifier NCT000608764.

Trial registration: ClinicalTrials.gov NCT00608764 NCT00608764.

Keywords: Akaike information criterion; chest imaging; chronic obstructive pulmonary disease; interobserver agreement.

Conflict of interest statement

Dr Spyridon Fortis reports grants from the American Thoracic Society and Fisher Paykel, outside the submitted work; and is a Consultant for Genentech. Dr Alejandro P Comellas reports grants from the National Institutes of Health, non-financial support from VIDA, during the conduct of the study; personal fees from GlaxoSmithKline, outside the submitted work. The authors report no other conflicts of interest in this work.

© 2021 Amaza et al.

Figures

Figure 1
Figure 1
Overlap of discordant groups from comparisons of University of Iowa radiologists versus quantitative computed tomography (QCT) and COPDGene radiologists versus QCT. (A) Visual-only emphysema. (B) Quantitative-only emphysema.
Figure 2
Figure 2
Continued.
Figure 2
Figure 2
Examples of discordant assessments. (A) The computed tomography was visually interpreted as negative for emphysema but emphysema was identified quantitatively; axial multiplanar reformat (MPR) (upper left), low attenuation area (LAA) percentages by lung lobe (upper right), axial MPR with LAA overlay (lower left), and topographic MPR (lower right) provided. Quantitative measures correlated with spirometry in this participant. (B) Visual-only identified emphysema. Small areas identified quantitatively but were not above the LAA ≤950 Hounsfield units 5% threshold; axial MPR (upper left), LAA percentages by lung lobe (upper right), axial MPR with LAA overlay (lower left), and topographic MPR (lower right) provided. Quantitative measures also correlated with spirometry. Images courtesy of VIDA, Coralville, Iowa, USA.
Figure 3
Figure 3
Factors associated with discordance (multivariable stepwise logistic regression) Adjusted analysis comparing quantitative-only emphysema and visual-only emphysema (University of Iowa). Variables tested but not retained in the final model: functional residual capacity percent predicted and chronic bronchitis.
Figure 4
Figure 4
Sensitivity of visually-detected emphysema at various quantitative computed tomography diagnostic thresholds.

References

    1. Lynch DA, Austin JH, Hogg JC, et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner society. Radiology. 2015;277(1):192–205. doi:10.1148/radiol.2015141579
    1. Barr RG, Berkowitz EA, Bigazzi F, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012;9(2):151–159. doi:10.3109/15412555.2012.654923
    1. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43. doi:10.3109/15412550903499522
    1. COPDGene. Clinical center manual of procedures. Version 5.0; 2009. Available from: . Accessed February11, 2021.
    1. Wan ES, Hokanson JE, Murphy JR, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184(1):57–63. doi:10.1164/rccm.201101-0021OC
    1. Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15:89. doi:10.1186/s12931-014-0089-y
    1. Lowe KE, Regan EA, Anzueto A, et al. COPDGene((R)) 2019: redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019;6(5):384–399.
    1. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
    1. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
    1. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS workshop on lung volume measurements. Official statement of the European respiratory society. Eur Respir J. 1995;8(3):492–506. doi:10.1183/09031936.95.08030492
    1. Brecthel L, Gainey J, Penwell A, Nathaniel TI. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients. BMC Neurol. 2018;18(1):215. doi:10.1186/s12883-018-1204-3
    1. Fortis S, Comellas A, Make BJ, et al. Combined forced expiratory volume in 1 second and forced vital capacity bronchodilator response, exacerbations, and mortality in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16(7):826–835. doi:10.1513/AnnalsATS.201809-601OC
    1. Fortis S, Eberlein M, Georgopoulos D, Comellas AP. Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes. BMJ Open Respir Res. 2017;4(1):e000213. doi:10.1136/bmjresp-2017-000213
    1. Burns RJ, Deschenes SS, Schmitz N. Associations between depressive symptoms and social support in adults with diabetes: comparing directionality hypotheses with a longitudinal cohort. Ann Behav Med. 2016;50(3):348–357. doi:10.1007/s12160-015-9760-x
    1. Park J, Hobbs BD, Crapo JD, et al. Subtyping COPD by using visual and quantitative CT imaging features. Chest. 2019;157(1):47–60.
    1. Hoffman EA, Ahmed FS, Baumhauer H, et al. Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study. Ann Am Thorac Soc. 2014;11(6):898–907. doi:10.1513/AnnalsATS.201310-364OC
    1. Tam A, Morrish D, Wadsworth S, Dorscheid D, Man SF, Sin DD. The role of female hormones on lung function in chronic lung diseases. BMC Womens Health. 2011;11:24. doi:10.1186/1472-6874-11-24
    1. Pompe E, van Rikxoort EM, Schmidt M, et al. Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(9):1084–1086. doi:10.1164/rccm.201411-2105LE
    1. Pompe E, Galban CJ, Ross BD, et al. Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease. Respir Med. 2017;123:48–55. doi:10.1016/j.rmed.2016.11.021
    1. Labaki WW, Gu T, Murray S, et al. Voxel-wise longitudinal parametric response mapping analysis of chest computed tomography in smokers. Acad Radiol. 2019;26(2):217–223. doi:10.1016/j.acra.2018.05.024
    1. Edge J, Simon G, Reid L. Peri-acinar (paraseptal) emphysema: its clinical, radiological, and physiological features. Br J Dis Chest. 1966;60(1):10–18. doi:10.1016/S0007-0971(66)80016-5
    1. Smith BM, Austin JH, Newell JD Jr, et al. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med. 2014;127(1):94 e97. doi:10.1016/j.amjmed.2013.09.020
    1. Araki T, Nishino M, Zazueta OE, et al. Paraseptal emphysema: prevalence and distribution on CT and association with interstitial lung abnormalities. Eur J Radiol. 2015;84(7):1413–1418. doi:10.1016/j.ejrad.2015.03.010
    1. Mouronte-Roibas C, Fernandez-Villar A, Ruano-Ravina A, et al. Influence of the type of emphysema in the relationship between COPD and lung cancer. Int J Chron Obstruct Pulmon Dis. 2018;13:3563–3570. doi:10.2147/COPD.S178109
    1. Galban CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711–1715. doi:10.1038/nm.2971

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner